Tel aviv israel oct.
Vasc q laminate med.
Value vascular access laminate european experience.
A post market surveillance study to assess the safety and effectiveness of vasq value the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Laminate medical technologies was founded in 2012 by tammy gilon and dr.
23 2019 prnewswire the israeli start up laminate medical technologies developer of the vasq external vascular support device for arteriovenous fistulas in patients.
Vasq laminate medical technologies israel is an external support device for avfs designed to improve flow and reduce neointimal hyperplasia at the anastomotic site.
Laminate medical technologies said today it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular.
Preliminary data are presented of its use assessing its safety and efficacy for brachiocephalic avfs in haemodialysis patients.
Eyal orion who began their work in the rad biomed incubator.
Listing a study does not mean it has been evaluated by the u s.
The israel based company s vasq device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure.